Delivery of superparamagnetic nanoparticles for local chemotherapy after intraarterial infusion and magnetic drug targeting

Anticancer Research

Volumn 27, Issue 4 A, 2007, Pages 2019-2022

  Alexiou, Christoph ^a   Jurgons, Roland ^a   Seliger, Christian ^a   Brunke, Oliver ^b   Iro, Heinrich ^a   Odenbach, Stefan ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Cancer treatment; Chemotherapy; Ferrofluids; Magnetic drug targeting; Magnetic nanoparticles

Indexed keywords

FERRIC FERROCYANIDE; MITOXANTRONE; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER CHEMOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; HISTOLOGY; MAGNETIC FIELD; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; X RAY;

ANIMALS; CARCINOMA, SQUAMOUS CELL; DRUG DELIVERY SYSTEMS; INFUSIONS, INTRA-ARTERIAL; MAGNETICS; METAL NANOPARTICLES; NEOPLASMS, EXPERIMENTAL; RABBITS; TISSUE DISTRIBUTION; X-RAYS;

EID: 34250691406     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Bilkenroth U, Taubert H, Riemann D, Rebmann U, Heynemann H and Meye A: Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation. Int J Cancer 92: 577-582, 2001.
2. Alksne JF, Fingerhut A and Rand R: Magnetically controlled metallic thrombosis of intracranial aneurysms. Surgery 60: 212-218,1966.
3. Taupitz M, Wagner S, Hamm B, Dienemann D, Lawaczeck R and Wolf KJ: MR Lymphography using iron oxide particles. Detection of lymph node metastases in the VX2 rabbit tumor model. Acta Radiol 34: 10-15, 1993.
4. Alexiou Ch, Arnold W, Klein R, Parak F, Hulin P, Bergemann C, Erhardt W, Wagenpfeil S and Lübbe AS: Locoregional cancer treatment with magnetic drug targeting. Cancer Res 60: 6641-6648, 2000.
5. Alexiou Ch, Jurgons R, Schmid RJ, Bergemann Ch, Henke J, Erhardt W, Huenges E and Parak FG: Magnetic drug targeting-biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J Drug Targeting 11: 139-149, 2003.
6. Alexiou C, Jurgons R, Schmid R, Erhardt W, Bergemann C and Parak F: Magnetisches drug targeting - ein neuer Ansatz in der lokoregionären tumortherapie mit chemotherapeutika. HNO 53: 618-622, 2005.
7. Gupta PK: Drug targeting in chemotherapy: a clinical perspective. J Pharm Sci 79: 949-962, 1990.
8. Torchilin VP: Drug targeting. Eur J Pharm Sci 11: 81-91, 2000.
9. Gupta PK and Hung CT: Comparative disposition of adriamycin delivered via magnetic albumin microspheres in presence and absence of magnetic fields in rats. Life Sci 46: 471-484, 1990.
10. Alexiou Ch, Jurgons R, Schmid RJ, Hilpert A, Bergemann Ch, Parak FG and Iro H: In vitro and in vivo investigations of targeted chemotherapy with magnetic nanoparticles. J Magn Magn Mater 293: 389-393, 2005.
11. Kohler N, Sun C, Wang J and Zhang M: Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. Langmuir 21: 8858-8864, 2005.
12. Alexiou Ch, Jurgons R, Seliger C, Kolb S, Heubeck B and Iro H: Distribution of mitoxantrone after magnetic drug targeting - fluorescence microscopic investigations on VX2 squamous cell carcinoma cells. Z Phys Chem 220: 235-240, 2006.
13. Collins JM: Pharmacological rationale for regional drug delivery. J Clin Oncol 2: 498-505, 1984.